Brief: Hungary's Richter says Tuyory received positive opinion from EMA committee
27/02/2026 11:27
Feb 27 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt GDRB.BU says: IT RECEIVED POSITIVE OPINION FROM EUROPEAN MEDICINES AGENCY'S COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE RECOMMENDING MARKETING AUTHORIZATION IN EUROPE FOR TUYORY TUYORY IS PROPOSED BIOSIMILAR TO ROCATEMRA'S TOCILIZUMAB Source text: [https://bse.hu/newkibdata/129406613/Tocilizumab%20EMA_Feb2026_EN.pdf] Further company coverage: GDRB.BU (Reporting by Anita Komuves) ((KOMUVES.Anita@thomsonreuters.com;))
Recent news on Richter Gedeon Vegyeszeti Gyar Nyrt
See all newsAI in Hungary could unlock productivity gains of €15 billion, McKinsey says
Brief: Hungary's Richter and Hetero announce cooperation for development of semaglutide injection
Brief: Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia
Brief: Hungary's Richter Says 2026 Guidance Fully Reiterated High-Single-Digit Growth In Revenues And Clean EBIT (At Constant Exchange Rates)
Brief: Hungary's Richter says European Commission granted approval for Tuyory, its biosimilar to Tocilizumab